Would you use neoadjuvant CDK4/6 inhibitor and AI in HR+ breast cancer based upon the randomized phase II CORALLEEN trial?
https://www.ncbi.nlm.nih.gov/pubmed/31838010
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Cedars-Sinai Medical Center
Answered on
I would not use CDK inhibitors in the neoadjuvant setting.
Join for free or sign in to see the full answer